3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Myeloid
1
Conditions
Myelodysplastic Syndromes
244
Leukemia, Myeloid, Acute
191
Leukemia
145
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
139
Precursor Cell Lymphoblastic Leukemia-Lymphoma
120
Myeloproliferative Disorders
89
Multiple Myeloma
84
Leukemia, Lymphocytic, Chronic, B-Cell
78
Lymphoma, Non-Hodgkin
76
Primary Myelofibrosis
72
Leukemia, Myelomonocytic, Chronic
69
Lymphoma
67
Hodgkin Disease
66
Leukemia, Myeloid, Chronic-Phase
55
Lymphoma, Mantle-Cell
50
Blast Crisis
49
Lymphoma, Large B-Cell, Diffuse
47
Lymphoma, Follicular
44
Leukemia, Myeloid, Accelerated Phase
44
Congenital Abnormalities
41
Lymphoma, B-Cell, Marginal Zone
40
Burkitt Lymphoma
40
Neoplasms, Plasma Cell
38
Lymphoma, Large-Cell, Immunoblastic
35
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
35
Polycythemia Vera
32
Hematologic Neoplasms
31
Myelodysplastic-Myeloproliferative Diseases
30
Lymphoma, T-Cell, Cutaneous
29
Anemia, Refractory, with Excess of Blasts
29
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Terminated
×
Chromosome Aberrations
×
Myeloid
×
Clear all
NCT00461929
2009-02-13
GIST
University Health Network, Toronto
Phase 4
Terminated
68 enrolled